Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia and other pregnancy complications. Founded by Dennis Farrar, Sean Esplin, and Steven Graves in 2008, Sera Prognostics is backed by investors that include Blue Ox Healthcare Partners, Catalyst Health Ventures, Domain Associates, InterWest Partners, and OUP (Osage University Partners) and is headquartered in Salt Lake City.
FOUNDED:
2008
INDUSTRY:
Biotechnology, Health Care, Hospital, Medical, Medical Device
FOUNDERS:
Dennis Farrar, Sean Esplin, Steven Graves
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
